NGS- Based RNA- Seq Market Forecast to Witness Comprehensive Growth by 2027
The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.
The global NGS- Based RNA- Seq Market was estimated to be worth US$ 1,240.87 Mn in 2017 and is expected to reach US$ 7,984.90 Mn by 2027, according to a market research study by The Insight Partners titled "NGS- Based RNA- Seq Market to 2027 - Global Analysis and Forecasts by Product & Services, Technology, Application and End User." From 2018 to 2027, the market is anticipated to expand at a CAGR of 19.3%. The study outlines the trends that are currently dominating the global NGS-based RNA-seq market, as well as the market drivers and market restrainers.
Due to factors such the declining cost of genome sequencing, improvements in sequencing technology, and the use of next-generation sequencing for cancer, the global NGS-based RNA-seq market is anticipated to expand in the next years. However, this business is constrained by the dangers associated with genetic data and the high price of NGS devices. However, in the next years, barcode scanning for long read sequences is projected to open up new potential for the NGS-based RNA-seq sector.
Get More Information @ https://www.theinsightpartners.com/reports/ngs-based-rna-seq-market
The global NGS-based RNA-seq market is divided into sample preparation, sequencing services, sequencing platform & consumables, and data analysis, storage, & management based on products & services. The portion for sample preparation is further divided into segments for methods and workflow steps. The segment by products & services with the biggest share in 2017 was sequencing platform & consumables. Additionally, it is projected that during the forecast period, the data analysis segment will expand significantly.
Thermo Fisher Scientific, Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc., and Eurofins Scientific are a few of the top companies competing in the NGS-based RNA-seq market. To maintain their place in the market, the market participants are concentrating on introducing fresh and cutting-edge product launches. One such example is the debut of Agilent OnePGT by Agilent Technologies Inc. in October 2018, which is a genome-wide next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT).
Get Sample Copy of Report PDF: https://www.theinsightpartners.com/sample/TIPBT00002556/
Global NGS- Based RNA- Seq Market - By Product & Services
Library Preparation & Target Enrichment
Fragmentation, End Repair & Size Selection
Sequencing Platform & Consumables
Data Analysis, Storage & Management
Global NGS- Based RNA- Seq Market - By Technology
Sequencing By Synthesis
Ion Semiconductor Sequencing
Single-Molecule Real-Time (SMRT) Sequencing
Global NGS- Based RNA- Seq Market - By Application
Global NGS-Based RNA-Seq Market - By End User
Hospitals & Clinics
Research Centers and Academic & Government Institutes
Biotechnology & Pharmaceutical Companies
Global NGS- Based RNA- Seq Market - By Geography
Asia Pacific (APAC)
Middle East & Africa (MEA)
South and Central America (SCAM)
Browse More Related Reports by the insight partners:
RNAi Therapeutics Market
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi